US stock · Healthcare sector · Medical Devices
Company Logo

Glaukos Corporation

GKOSNYSE

41.60

USD
+0.95
(+2.34%)
Market Closed
-70.54P/E
-32Forward P/E
-2.72P/E to S&P500
1.969BMarket CAP
- -Div Yield
Scale: |
View:
Currency: USD, in millions
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
21
46
72
114
159
181
237
225
294
COGS
3
11
13
16
21
25
39
92
67
Gross Profit
18
34
59
98
138
156
198
133
227
Gross Profit Ratio
87.90%
74.95%
81.89%
85.86%
86.78%
86.17%
83.72%
59.23%
77.34%
Operating Expenses
33
47
69
94
140
169
245
257
280
R&D Expenses
16
19
25
29
44
50
68
85
101
Selling, G&A Exp.
- -
- -
44
65
96
120
177
171
179
General and Admin. Exp.
- -
- -
44
65
96
120
- -
- -
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
17
28
- -
- -
- -
- -
- -
- -
- -
COGS and Expenses
35
59
82
110
162
194
284
349
347
Interest Income
0
0
0
1
2
2
3
2
1
Interest Expense
0
1
1
1
0
- -
3
14
13
Depreciation and Amortization
1
4
4
5
5
6
10
35
34
EBITDA
(11)
(7)
(32)
10
6
(6)
(38)
(84)
(1)
EBITDA ratio
(53.32)%
(15.36)%
(44.46)%
8.65%
3.47%
(3.37)%
(15.87)%
(37.16)%
(0.50)%
Operating Income
(14)
(13)
(10)
4
(2)
(13)
(50)
(124)
(33)
Operating Income ratio
(67.78)%
(28.89)%
(14.36)%
3.71%
(1.43)%
(7.17)%
(21.22)%
(54.92)%
(11.18)%
Total Other Income Exp.(Gains)
(0)
(1)
(28)
0
2
1
0
(9)
(16)
Income Before Tax
(14)
(14)
(38)
5
0
(12)
(50)
(132)
(49)
Income Before Tax ratio
(67.89)%
(30.80)%
(53.40)%
3.99%
0.00%
(6.82)%
(21.11)%
(58.82)%
(16.76)%
Income Tax Expense (Gain)
0
0
0
0
0
1
(65)
(12)
0
Net Income
(13)
(12)
(37)
5
(0)
(13)
15
(120)
(50)
Net Income Ratio
(60.34)%
(26.60)%
(51.94)%
3.95%
(0.06)%
(7.14)%
6.51%
(53.50)%
(16.87)%
EPS
(0.51)
(0.51)
(2.13)
0.14
(0.00)
(0.37)
0.41
(2.70)
(1.07)
EPS Diluted
(0.51)
(0.51)
(2.13)
0.12
(0.00)
(0.37)
0.37
(2.70)
(1.07)
Weighted Avg. Shares Outs.
25
24
17
33
34
35
37
44
47
Weighted Avg. Shares Outs. Dil.
25
24
17
36
34
35
41
44
49
Balance Sheet
Cash and Cash Equivalents
7
2
22
6
25
30
62
97
101
Short-Term Investments
- -
- -
70
89
95
111
112
308
313
Cash & Short-Term Investments
7
2
91
96
119
140
174
404
414
Net Receivables
3
5
8
14
17
19
38
36
33
Inventory
2
2
4
7
11
13
43
16
23
Other Current Assets
0
1
1
3
3
4
8
13
16
Total Current Assets
12
11
104
120
149
177
263
469
486
PP&E
2
2
2
8
12
19
92
95
146
Goodwill
- -
- -
- -
- -
- -
- -
66
66
66
Intangible Assets
17
13
10
7
3
- -
383
358
333
Goodwill and Intangible Assets
17
13
10
7
3
- -
449
424
399
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tax Assets
- -
- -
- -
- -
0
0
- -
- -
- -
Other Non-Current Assets
0
0
0
0
1
11
15
17
19
Total Non-Current Assets
19
15
13
14
16
30
556
536
564
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
31
26
117
134
166
207
818
1,006
1,050
Accounts Payable
3
3
4
3
6
6
6
4
7
Short-Term Debt
- -
10
9
- -
- -
- -
- -
- -
- -
Tax Payable
- -
- -
- -
- -
- -
- -
- -
3
- -
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Current Liabilities
2
7
8
14
21
24
52
45
56
Total Current Liabilities
5
20
20
17
27
30
58
50
63
Long-Term Debt
18
9
1
- -
- -
- -
73
271
382
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
10
11
7
Other Non-Current Liabilities
1
0
0
0
1
3
5
7
9
Total Non-Current Liabilities
18
9
1
0
1
3
87
288
399
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
- -
- -
- -
73
81
102
Total Liabilities
24
30
21
17
28
33
145
338
463
Preferred Stock
156
157
- -
- -
- -
- -
- -
- -
- -
Common Stock
0
0
0
0
0
0
0
0
0
Retained Earnings
(147)
(159)
(197)
(192)
(192)
(205)
(190)
(310)
(365)
Other Compreh. Income(Loss)
0
0
0
1
(1)
1
1
1
0
Other Total Stockhold. Equity
6
8
292
309
331
378
862
976
952
Total Stockholders Equity
15
6
95
117
138
174
673
667
587
Total Liab.&Stockhold. Equity
39
36
117
134
166
207
818
1,006
1,050
Minority Interest
(8)
(10)
- -
- -
- -
- -
- -
- -
- -
Total Liabilities & Equity
31
26
117
134
166
207
818
1,006
1,050
Cash Flow Statement
Net Income
(13)
(12)
(37)
5
(0)
(13)
15
(120)
(50)
Depreciation and Amortization
1
4
4
5
5
6
10
35
34
Deferred Income Tax
- -
- -
- -
- -
- -
- -
(66)
(12)
(1)
Stock Based Compensation
1
2
8
9
18
26
36
46
30
Change in Working Capital
(1)
1
(3)
(6)
3
(4)
(4)
(3)
4
Accounts Receivable
(2)
(3)
(2)
(7)
(2)
(2)
(7)
2
2
Inventory
(1)
(0)
(2)
(3)
(4)
(2)
4
2
(8)
Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Working Capital
(0)
0
(0)
0
(0)
0
(2)
0
- -
Other Non-Cash Items
(2)
(2)
26
1
(0)
3
9
32
7
Cash Provided by Operating Activities
(13)
(7)
(2)
12
26
19
(0)
(23)
25
CAPEX
(1)
(1)
(1)
(6)
(6)
(10)
(5)
(7)
(48)
Acquisitions Net
- -
- -
(15)
- -
- -
- -
50
- -
- -
Purchases of Investments
(11)
- -
(70)
(75)
(94)
(95)
(82)
(303)
(217)
Sales/Maturities of Investments
11
- -
- -
55
89
79
80
105
207
Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
0
Cash Used for Investing Activities
(1)
(1)
(86)
(26)
(12)
(26)
43
(205)
(58)
Debt Repayment
- -
- -
(18)
(10)
- -
- -
(22)
- -
(1)
Common Stock Issued
- -
- -
114
- -
- -
- -
- -
- -
- -
Common Stock Repurchased
(0)
- -
- -
- -
- -
- -
- -
- -
- -
Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Financing Activities
19
4
12
8
5
22
13
263
40
Cash Used/Provided by Financing Activities
19
4
107
(2)
5
22
(10)
263
39
Effect of Forex Changes on Cash
0
0
(0)
0
(0)
0
(0)
(0)
(2)
Net Change In Cash
5
(4)
19
(15)
18
14
33
34
4
Cash at the End of Period
7
2
22
6
25
39
72
106
110
Cash at the Beginning of Period
2
7
2
22
6
25
39
72
106
Free Cash Flow
(14)
(8)
(3)
6
19
9
(5)
(30)
(23)
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -